Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Johnson & Johnson (

Johnson & Johnson to pay $700m to settle claims it misled consumers

Pharmaceutical giant’s payout settles allegations it misled consumers about safety of its talcum-based powder products.

Al Jazeera

Top 4 Pharma Stocks for Long-Term Value Investors in 2024

The pharmaceutical sector is experiencing rapid growth thanks to the rising demand for precision drugs, the growing geriatric population, and an uptick in chronic diseases. Given this backdrop, long-term value investors could consider buying and holding quality pharmaceutical stocks such as Organon (OGN), Procaps (PROC), Johnson & Johnson (JNJ), and…

StockNews.com

Cancer Victims Sue Johnson & Johnson Over Bankruptcy Allegations

Johnson & Johnson faces legal action over alleged fraudulent bankruptcies related to talc products causing cancer.

Top News

From analysis to the latest developments in health,
read the most diverse news in one place.

5 Standout Healthcare Dividend Stocks to Consider Now

Amid healthcare’s enduring importance and increasing demand for its products and services, here are five dividend-paying healthcare stocks to consider now.

Barchart

J&J Unveils Landmark $6.5 Billion Settlement With Baby Powder Ovarian Cancer Claimants

J&J has reached a new $6.5 billion settlement with those who claimed that the company's baby powder causes ovarian cancer.

International Business Times

Medical device companies pay millions to NHS while pushing products, says study

Pharmaceutical equipment firms are funding NHS staff and training while promoting sales

The Guardian - UK

WHO To Issue Alert On Contaminated J&J Cough Syrup

WHO may issue a broader alert for contaminated Johnson & Johnson cough syrup in Africa, highlighting public health risks and the importance of regulatory v...

Top News

Read news from The Economist, FT, and more,
with one subscription

J&J Prevails In Talc Lawsuit Over Cancer Allegations

Johnson & Johnson wins trial over cancer claims related to baby powder in Florida. Company maintains product safety amidst ongoing legal battles.

Top News

Top Companies Leading In Corporate Governance Practices

Discover the top 10 companies with exceptional corporate governance practices, including Apple, Microsoft, and Johnson & Johnson.

Top News

Stocks Mixed on Rising Bond Yields

The S&P 500 Index ($SPX ) (SPY ) this morning is down -0.13%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.36%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.05%. Stock indexes this morning are mixed, with the Nasdaq 100 falling to a...

Barchart

JNJ Earnings Forecast - Is Pharmaceutical Industry Set for Shake-up?

As pharma titan Johnson & Johnson (JNJ) gears up to unveil its first-quarter results on April 16, 2024, anticipation looms over the pharmaceutical industry. JNJ’s recent acquisitions signal the company’s strategic expansions, and given its history as one of the prominent pharma companies, is JNJ’s forecast as stunning? Let us…

StockNews.com

Stock Index Futures are Higher after Wholesale Prices Increased Less Than Expected in March

June S&P 500 E-Mini futures (ESM24) are up 0.02%, and June Nasdaq 100 E-Mini futures (NQM24) are up 0.17%% this morning, after the release of the PPI data.

Barchart

Stock Index Futures Slip as Rate Cut Hopes Fade, U.S. PPI Data and ECB Decision in Focus

June S&P 500 E-Mini futures (ESM24) are down -0.36%, and June Nasdaq 100 E-Mini futures (NQM24) are down -0.30% this morning, signaling further losses on Wall Street after hotter-than-expected U.S. inflation data diminished hopes of early interest rate cuts by the Federal Reserve, while investors awaited crucial U.S. producer inflation…

Barchart

Johnson & Johnson Acquires Shockwave Medical For Billion

Johnson & Johnson invests billion to acquire Shockwave Medical, a leader in heart care technology.

Top News

Get all your
news in one place.

100's of premium titles.
One news app.

Top News

J&J Advises Shareholders Against TRC Capital 'Mini-Tender' Offer

Johnson & Johnson advises shareholders to reject TRC Capital's mini-tender offer below market value, emphasizing caution and protection of shareholder inte...

Top News

Johnson & Johnson Poised For Growth Despite Recent Challenges

Johnson & Johnson (NYSE: JNJ) poised for growth despite challenges, with analysts estimating a 10% upside. Resilient in market fluctuations, key drivers in...

StockNews.com

4 Pharma Titans Making Waves in Wall Street

The pharma industry is well-positioned to remain buoyed, owing to the rise in chronic diseases, a growing elderly population, and the integration of advanced technologies. Given this backdrop, quality pharma stocks Bristol-Myers Squibb Company (BMY), Johnson & Johnson (JNJ), Novartis AG (NVS), and Merck & Co. (MRK), making waves in…

StockNews.com

3 Pharma Stocks With Prescription for Stability and Value in March

Amid rising healthcare demand globally, advancements in precision medicine, and the booming e-pharmacy market, the pharmaceutical industry is expected to witness significant long-term growth. Hence, fundamentally sound pharma stocks Dr. Reddy’s Laboratories (RDY), Ipsen (IPSEY), and Johnson & Johnson (JNJ), which boast low beta values and attractive valuation metrics, might…

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

4 Top Dividend Kings to Earn Passive Income

Dividend Kings are companies with a long history of paying and increasing shareholder dividends, which signals strong financial health for investors looking to build a steady stream of passive income.

International Business Times

20 Highest-Grossing Biotech Stocks: Giants Driving Innovation and Growth

Biotech stocks offers the potential for significant returns driven by breakthrough discoveries and advancements in healthcare, agriculture, and other industries.

StockNews.com

Pfizer (PFE) vs. Johnson & Johnson (JNJ) - Analyzing Pharma Stocks for Upside Potential

The pharmaceutical industry is expected to witness robust growth over the coming years due to growing healthcare needs and advancements in technology. Given this positive backdrop, let’s analyze the upside potential of pharma stocks Pfizer (PFE) and Johnson & Johnson (JNJ).

WEKU

Senators ask CEOs why their drugs cost so much more in the U.S.

The Senate HELP committee questioned pharmaceutical CEOs about how much more Americans pay for the same drugs sold for less in Canada, Japan and Europe.

Roll Call

Merck, Johnson & Johnson CEOs agree to appear before Senate HELP - Roll Call

Two drug company CEOs have agreed to testify before the Senate HELP Committee on drug prices, avoiding a scheduled subpoena vote on Jan. 31.

StockNews.com

Johnson & Johnson (JNJ): Analyzing Signals Before Quarterly Earnings

Pharmaceutical powerhouse Johnson & Johnson (JNJ) is proactively driving innovation throughout the healthcare spectrum, thanks to its strong focus on innovative medicines and MedTech solutions. However, with the company’s fiscal fourth-quarter earnings on the horizon, could the stock be a wise portfolio addition? Keep reading to find out….

The Guardian - US

Families condemn Koch brothers over ploy to avoid asbestos compensation

Georgia-Pacific, owned by Koch Industries, employ controversial legal tactic to circumvent paying millions to sickened workers

1 … 9 10 11 12

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.